206 related articles for article (PubMed ID: 12917957)
1. Treatment of Kaposi's sarcoma in HIV-1 infected individuals with emphasis on resource poor settings.
Dedicoat M; Vaithilingum M; Newton R
Cochrane Database Syst Rev; 2003; (3):CD003256. PubMed ID: 12917957
[TBL] [Abstract][Full Text] [Related]
2. Treatment of severe or progressive Kaposi's sarcoma in HIV-infected adults.
Gbabe OF; Okwundu CI; Dedicoat M; Freeman EE
Cochrane Database Syst Rev; 2014 Aug; 8(8):CD003256. PubMed ID: 25221796
[TBL] [Abstract][Full Text] [Related]
3. Treatment of severe or progressive Kaposi's sarcoma in HIV-infected adults.
Gbabe OF; Okwundu CI; Dedicoat M; Freeman EE
Cochrane Database Syst Rev; 2014; (9):CD003256. PubMed ID: 25313415
[TBL] [Abstract][Full Text] [Related]
4. Interventions for the prevention and management of oropharyngeal candidiasis associated with HIV infection in adults and children.
Pienaar ED; Young T; Holmes H
Cochrane Database Syst Rev; 2006 Jul; (3):CD003940. PubMed ID: 16856025
[TBL] [Abstract][Full Text] [Related]
5. Cotrimoxazole prophylaxis for opportunistic infections in adults with HIV.
Grimwade K; Swingler ; G
Cochrane Database Syst Rev; 2003; 2003(3):CD003108. PubMed ID: 12917946
[TBL] [Abstract][Full Text] [Related]
6. Treatment of AIDS-related cutaneous Kaposi's sarcoma with topical alitretinoin (9-cis-retinoic acid) gel. Panretin Gel North American Study Group.
Walmsley S; Northfelt DW; Melosky B; Conant M; Friedman-Kien AE; Wagner B
J Acquir Immune Defic Syndr; 1999 Nov; 22(3):235-46. PubMed ID: 10770343
[TBL] [Abstract][Full Text] [Related]
7. Therapy of special HIV-associated diseases: HCV-HIV-co-infection and AIDS-related Kaposi's sarcoma - official satellite to the 7th European Conference on Clinical Aspects and Treatment of HIV-infection, October 23, 1999 in Lisbon, Portugal.
Goebel FD; Jablonowski H
Eur J Med Res; 1999 Dec; 4(12):507-13. PubMed ID: 10611054
[TBL] [Abstract][Full Text] [Related]
8. Treatment of latent tuberculosis infection in HIV infected persons.
Woldehanna S; Volmink J
Cochrane Database Syst Rev; 2004; (1):CD000171. PubMed ID: 14973947
[TBL] [Abstract][Full Text] [Related]
9. Phase III vehicle-controlled, multi-centered study of topical alitretinoin gel 0.1% in cutaneous AIDS-related Kaposi's sarcoma.
Bodsworth NJ; Bloch M; Bower M; Donnell D; Yocum R;
Am J Clin Dermatol; 2001; 2(2):77-87. PubMed ID: 11705307
[TBL] [Abstract][Full Text] [Related]
10. Population-based interventions for reducing sexually transmitted infections, including HIV infection.
Wilkinson D; Rutherford G
Cochrane Database Syst Rev; 2001; (2):CD001220. PubMed ID: 11405980
[TBL] [Abstract][Full Text] [Related]
11. Topical treatment of cutaneous lesions of acquired immunodeficiency syndrome-related Kaposi sarcoma using alitretinoin gel: results of phase 1 and 2 trials.
Duvic M; Friedman-Kien AE; Looney DJ; Miles SA; Myskowski PL; Scadden DT; Von Roenn J; Galpin JE; Groopman J; Loewen G; Stevens V; Truglia JA; Yocum RC
Arch Dermatol; 2000 Dec; 136(12):1461-9. PubMed ID: 11115156
[TBL] [Abstract][Full Text] [Related]
12. A risk and benefit assessment of treatment for AIDS-related Kaposi's sarcoma.
Nasti G; Errante D; Santarossa S; Vaccher E; Tirelli U
Drug Saf; 1999 May; 20(5):403-25. PubMed ID: 10348092
[TBL] [Abstract][Full Text] [Related]
13. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
Siegfried N; van der Merwe L; Brocklehurst P; Sint TT
Cochrane Database Syst Rev; 2011 Jul; (7):CD003510. PubMed ID: 21735394
[TBL] [Abstract][Full Text] [Related]
14. Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.
Sturt AS; Dokubo EK; Sint TT
Cochrane Database Syst Rev; 2010 Mar; (3):CD008440. PubMed ID: 20238370
[TBL] [Abstract][Full Text] [Related]
15. Vitamin A supplementation for reducing the risk of mother-to-child transmission of HIV infection.
Shey WI; Brocklehurst P; Sterne JA
Cochrane Database Syst Rev; 2002; (3):CD003648. PubMed ID: 12137702
[TBL] [Abstract][Full Text] [Related]
16. Rifamycins (rifampicin, rifabutin and rifapentine) compared to isoniazid for preventing tuberculosis in HIV-negative people at risk of active TB.
Sharma SK; Sharma A; Kadhiravan T; Tharyan P
Evid Based Child Health; 2014 Mar; 9(1):169-294. PubMed ID: 25404581
[TBL] [Abstract][Full Text] [Related]
17. Alitretinoin.
Cheer SM; Foster RH
Am J Clin Dermatol; 2000; 1(5):307-14; discussion 315-6. PubMed ID: 11702321
[TBL] [Abstract][Full Text] [Related]
18. Management of AIDS-related Kaposi's sarcoma: advances in target discovery and treatment.
Dezube BJ
Expert Rev Anticancer Ther; 2002 Apr; 2(2):193-200. PubMed ID: 12113241
[TBL] [Abstract][Full Text] [Related]
19. HIV-associated Kaposi's sarcoma.
Jessop S
Dermatol Clin; 2006 Oct; 24(4):509-20, vii. PubMed ID: 17010779
[TBL] [Abstract][Full Text] [Related]
20. Pegylated-liposomal doxorubicin versus doxorubicin, bleomycin, and vincristine in the treatment of AIDS-related Kaposi's sarcoma: results of a randomized phase III clinical trial.
Northfelt DW; Dezube BJ; Thommes JA; Miller BJ; Fischl MA; Friedman-Kien A; Kaplan LD; Du Mond C; Mamelok RD; Henry DH
J Clin Oncol; 1998 Jul; 16(7):2445-51. PubMed ID: 9667262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]